Author Interviews, Cancer Research, NEJM, NIH, OBGYNE / 05.12.2024
NEJM: Prenatal cell-free DNA Can Detect Occult Maternal Cancer
MedicalResearch.com Interview with:
[caption id="attachment_65321" align="alignleft" width="92"]
Dr. Bianchi[/caption]
Diana W. Bianchi, M.D.
Senior Investigator
Center for Precision Health Research
Director,
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institutes of Health
MedicalResearch.com: What is the background for this study?
Response: The ability of prenatal cell-free DNA (cfDNA) sequencing to incidentally detect maternal cancers has been demonstrated by several retrospective studies from commercial or national laboratories. However, there are no standardized approaches to the identification and medical management of prenatal screening results that might indicate a maternal cancer. We sought to prospectively identify DNA sequencing patterns and other biomarkers that could distinguish which women with nonreportable or unusual cfDNA sequencing results had cancer and to determine the best approach for diagnostic work-up of pregnant people who receive these results.
Dr. Bianchi[/caption]
Diana W. Bianchi, M.D.
Senior Investigator
Center for Precision Health Research
Director,
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institutes of Health
MedicalResearch.com: What is the background for this study?
Response: The ability of prenatal cell-free DNA (cfDNA) sequencing to incidentally detect maternal cancers has been demonstrated by several retrospective studies from commercial or national laboratories. However, there are no standardized approaches to the identification and medical management of prenatal screening results that might indicate a maternal cancer. We sought to prospectively identify DNA sequencing patterns and other biomarkers that could distinguish which women with nonreportable or unusual cfDNA sequencing results had cancer and to determine the best approach for diagnostic work-up of pregnant people who receive these results.
Elena Stains
Medical Student
Department of Medical Education
Geisinger Commonwealth School of Medicine
Scranton, PA
MedicalResearch.com: What is the background for this study?
Response: Opioid use has been an increasing problem since the early 2000s in the United States (US) with a surge around 2010. Twenty-five percent of those having abused pain relievers in 2013 and 2014 got those drugs from physicians1. Physicians are particularly well-known for fueling the opioid crisis in Florida in the 2000s. Of the United States’ top 100 opioid prescribing physicians in 2010, an astounding 98 were prescribing in Florida2. Florida taking the main stage of the opioid crisis can be attributed to several factors, including ability of physicians to dispense opioids directly from their offices to patients (i.e. without pharmacists) and the presence of many infamous “pill mills” in the state3–6.
The researchers at Geisinger Commonwealth School of Medicine aimed to analyze the amount of hydrocodone (including brand names of Vicodin and Lortab) and oxycodone (OxyContin and Percocet) distributed in Florida from 2006 to 2021, paying close attention to the peak year of the opioid crisis, 2010. The team used the Washington Post and the US Drug Enforcement Administration’s Automation of Reports and Consolidated Orders System (ARCOS) databases to compile this compelling information.
Dr. Hagobian[/caption]
Todd Hagobian, Ph.D.
pronouns he/him/his
Department Chair & Professor, Kinesiology and Public Health
Cal Poly, San Luis Obispo, CA
MedicalResearch.com: What is the background for this study?
Response: Previous observational studies have shown that urinary BPA is related to Type 2 diabetes risk. Meaning, higher urinary BPA is related to an increased risk of Type 2 diabetes. However, no published study to date has determined whether several days of BPA administration (participants consume BPA) increases the risk of Type 2 diabetes.
MedicalResearch.com: Where is bisphenol found? Can exposure to bisphenol be limited in everyday life?
Response: BPA and other bisphenols are found in canned foods and plastics. BPA is one of the most widely used synthetic chemicals and we consume foods that are packed in this chemical. Most of BPA exposure comes from canned foods, and 93% of the US populations has detectable urine levels of BPA. We can limit BPA by reducing canned foods (or purchased BPA free cans) and plastic use.
Ben Petrazzini[/caption]
Ben Omega Petrazzini, B.Sc.
Associate Bioinformatician
Dr. Kosinski[/caption]
Dr. Larry Kosinski, MD
Gastroenterologist and
Remember those hot summer days when all we wanted was to come home from school and ride a bike around the neighborhood? Is this a familiar scenario for you? If yes, you've come to the right (digital) place because we discuss the benefits of cycling for all generations.
According to the Daily Nurse, nursing is
Dr. Haigh[/caption]
Cathryn Haigh, Ph.D.